Esperion Therapeutics

Esperion Therapeutics, Inc. (Nasdaq: ESPR) is a commercial-stage pharmaceutical company based in Ann Arbor, Michigan, focused on discovering, developing, and commercializing innovative medicines that lower LDL cholesterol and reduce cardiovascular risk. Its lead products are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe), oral, once-daily, non-statin therapies indicated to lower elevated LDL-C in adults. As a life-sciences company, Esperion operates a corporate and scientific marketing web presence rather than a developer program; it publishes no public API, developer portal, SDKs, or technical documentation. This profile was added to the API Evangelist network as a venture-portfolio lead and enriched with verifiable company identity and domain-security signals only.

Esperion Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Pharmaceutical, Biotechnology, Life Sciences, and Cardiovascular.

Esperion Therapeutics’ developer surface includes support and 4 more developer resources.

14.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyPharmaceuticalBiotechnologyLife SciencesCardiovascularHealthcareTherapeutics

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 14.6/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.9 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/esperion-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Esperion Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: esperion-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/esperion-therapeutics.png
name: Esperion Therapeutics
description: 'Esperion Therapeutics, Inc. (Nasdaq: ESPR) is a commercial-stage pharmaceutical company based in Ann Arbor,
  Michigan, focused on discovering, developing, and commercializing innovative medicines that lower LDL cholesterol and reduce
  cardiovascular risk. Its lead products are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe), oral,
  once-daily, non-statin therapies indicated to lower elevated LDL-C in adults. As a life-sciences company, Esperion operates
  a corporate and scientific marketing web presence rather than a developer program; it publishes no public API, developer
  portal, SDKs, or technical documentation. This profile was added to the API Evangelist network as a venture-portfolio lead
  and enriched with verifiable company identity and domain-security signals only.'
url: https://raw.githubusercontent.com/api-evangelist/esperion-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-api-surface: none
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Pharmaceutical
- Biotechnology
- Life Sciences
- Cardiovascular
- Healthcare
- Therapeutics
apis: []
common:
- type: Website
  url: https://www.esperion.com/
- type: PrivacyPolicy
  url: https://www.esperion.com/privacy-policy
- type: TermsOfService
  url: https://www.esperion.com/terms-use
- type: Support
  url: https://www.esperion.com/contact-us
- type: DomainSecurity
  url: security/esperion-therapeutics-domain-security.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence